Update on coagulase-negative staphylococci—what the clinician should know

R Michels, K Last, SL Becker, C Papan - Microorganisms, 2021 - mdpi.com
Coagulase-negative staphylococci (CoNS) are among the most frequently recovered bacteria
in routine clinical care. Their incidence has steadily increased over the past decades in …

Pneumocystis jirovecii Pneumonia and Severe Acute Respiratory Syndrome Coronavirus 2 Coinfection in a Patient With Newly Diagnosed HIV-1 Infection

…, A Maßmann, SL Becker, C Papan… - Clinical Infectious …, 2021 - academic.oup.com
We thank Fernandez-Cruz et al for their thoughtful comments in explaining the right time to
initiate corticosteroids for coronavirus 2019 (COVID-19). We are eager to read their article …

Assessment of the multiplex PCR-based assay Unyvero pneumonia application for detection of bacterial pathogens and antibiotic resistance genes in children and …

C Papan, M Meyer-Buehn, G Laniado, T Nicolai… - Infection, 2018 - Springer
Background Pneumonia is a major healthcare problem. Rapid pathogen identification is
critical, but often delayed due to the duration of culturing. Early, broad antibacterial therapy …

Policies on children and schools during the SARS-CoV-2 pandemic in Western Europe

…, M Mossberg, T Muka, A Munro, C Papan… - Frontiers in public …, 2023 - frontiersin.org
During the pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2),
mitigation policies for children have been a topic of considerable uncertainty and …

[HTML][HTML] A host signature based on TRAIL, IP-10, and CRP for reducing antibiotic overuse in children by differentiating bacterial from viral infections: a prospective …

C Papan, A Argentiero, M Porwoll, U Hakim… - Clinical Microbiology …, 2022 - Elsevier
Objectives Identifying infection aetiology is essential for appropriate antibiotic use. Previous
studies have shown that a host-protein signature consisting of TNF-related apoptosis-…

Mycoplasma pneumoniae: delayed re-emergence after COVID-19 pandemic restrictions

…, D Goldenberger, B Ivan, PM Keller, C Papan… - The Lancet …, 2024 - thelancet.com
Mycoplasma pneumoniae is a common cause of respiratory tract infections with community-acquired
pneumonia as the major disease-related burden. Compared with other pathogens, …

Mycoplasma pneumoniae beyond the COVID-19 pandemic: where is it?

…, A Egli, U Heininger, C Schlaeppi, C Papan… - The Lancet …, 2022 - thelancet.com
Mycoplasma pneumoniae beyond the COVID-19 pandemic: where is it? Page 1 Correspondence
www.thelancet.com/microbe Vol 3 December 2022 e897 Mycoplasma pneumoniae …

Association between women's authorship and women's editorship in infectious diseases journals: a cross-sectional study

…, SE Müller, A Huttner, C Papan - The Lancet Infectious …, 2022 - thelancet.com
Background Gender inequity is still pervasive in academic medicine, including journal
publishing. We aimed to ascertain the proportion of women among first and last authors and …

[HTML][HTML] TNF-related apoptosis-inducing ligand, interferon gamma-induced protein 10, and C-reactive protein in predicting the progression of SARS-CoV-2 infection: a …

…, SL Becker, M Krawczyk, PM Lepper, C Papan - International Journal of …, 2022 - Elsevier
Background Early prognostication of COVID-19 severity will potentially improve patient care.
Biomarkers, such as TNF-related apoptosis-inducing ligand (TRAIL), interferon gamma-…

Association of viral load with TRAIL, IP‐10, CRP biomarker signature and disease severity in children with respiratory tract infection or fever without source: A …

C Papan, A Argentiero, O Adams… - Journal of Medical …, 2023 - Wiley Online Library
Cihan Papan has performed other clinical research in collaboration with MeMed funded by
a grant awarded to MeMed, European Commission, Executive Agency for Small and Medium-…